MYGN
$12.28
Revenue | $213.3Mn |
Net Profits | $-22.1Mn |
Net Profit Margins | -10.36% |
Myriad Genetics Inc.’s revenue jumped 11.15% since last year same period to $213.3Mn in the Q3 2024. On a quarterly growth basis, Myriad Genetics Inc. has generated 0.85% jump in its revenue since last 3-months.
Myriad Genetics Inc.’s net profit jumped 63.95% since last year same period to $-22.1Mn in the Q3 2024. On a quarterly growth basis, Myriad Genetics Inc. has generated 39.78% jump in its net profits since last 3-months.
Myriad Genetics Inc.’s net profit margin jumped 67.56% since last year same period to -10.36% in the Q3 2024. On a quarterly growth basis, Myriad Genetics Inc. has generated 40.29% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.02 |
EPS Estimate Current Year | 0.02 |
Myriad Genetics Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.02 - a 300% jump from last quarter’s estimates.
Myriad Genetics Inc.’s earning per share (EPS) estimates for the current year stand at 0.02.
Earning Per Share (EPS) | 0.06 |
Myriad Genetics Inc.’s earning per share (EPS) jumped 300% since last year same period to 0.06 in the Q3 2024. This indicates that the Myriad Genetics Inc. has generated 300% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-08-07 | -0.01 | 0.05 | 600% |
2024-05-08 | -0.1 | -0.01 | 90% |
2024-11-08 | 0.02 | 0.06 | 200% |